# Centrally Acting Anti-Hypertensives {#id}

|Property|Clonidine
|--|--|
|**Class**|Central α<sub>2</sub>-agonist
|**Uses**| Analgesia, sedation, anti-hypertensive
|**Presentation**| Clear colourless solution at 150μg.ml<sup>-1</sup>
|**Route of Administration**| PO/IV
|**Dosing**| 50-200μg QID
|**Absorption**|100% PO bioavailability with rapid absorption
|**Distribution**|20% bound, V<sub>D</sub> 2L.kg<sup>-1</sup>
|**Metabolism**|50% hepatic to inactive metabolites
|**Elimination**|50% renal elimination unchanged
|**CVS**|Initial ↑ in BP followed by prolonged ↓, ↑ PR, ↓ AV conduction, ↑ baroreceptor sensitisation (lower HR for a given increase in BP)
|**CNS**| Sedation, analgesia. Anxiolysis at low doses
|**Metabolic**|Stress response to surgical stimulus is inhibited
|**Renal**| Diuresis secondary to inhibition of ADH


---
##References
Peck and Hill